T2 BiosystemsTTOO

13F holders, Q2 2024 (June 30)
21holders +2
6new positions
3sold out
$5.34avg. 13F price*

At the end of Q2 2024, 21 institutions reported holding T2 Biosystems Inc. (TTOO) in their 13F filings, up 2 from Q1 2024. 6 opened new positions and 3 sold out. The largest holders were Armistice Capital, LLC ($8.9M), Vanguard Group Inc. ($1.7M) and Geode Capital Management, LLC ($696K).

Company
T2 Biosystems Inc.
CUSIP
89853L302
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q1 2024: 19Q1 2024Q2 2024: 21Q2 2024Q3 2024: 21Q3 2024Q4 2024: 26Q4 2024Q1 2025: 2Q1 2025Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions6$9.5M
Exits3$40K

All 13F filers, Q1 2024 → Q2 2024: 2,193,367 shares bought and 16,008 shares sold, net +2,177,359 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 21 holders

Armistice Capital, LLC 0.23% New 1,658,000 $8.9M
Vanguard Group Inc. 0.00% Add +584.3% 312,701 $1.7M
Geode Capital Management, LLC 0.00% Add +368.4% 130,389 $696K
BlackRock Inc. 0.00% Add +111.8% 78,298 $418K
State Street Corp. 0.00% New 63,743 $340K
Susquehanna International Group, LLP 0.00% Add +1.2% 41,664 $222K
Northern Trust Corp. 0.00% New 38,879 $208K
Goldman Sachs Group Inc. 0.00% New 14,705 $79K
Tower Research Capital LLC (TRC) 0.00% Add +168.3% 7,667 $41K
Royal Bank of Canada 0.00% Add +106.3% 2,855 $15K
Group One Trading LLC 0.00% Reduce -50.6% 1,010 $5K
Cwm, LLC 0.00% No change 310 $2K
Osaic Holdings, Inc. 0.00% Add +2177.8% 205 $1K
Bank of America Corp. 0.00% Add +6300.0% 128 $684
International Assets Investment Management, LLC 0.00% New 33 $176
JPMorgan Chase & Co. 0.00% New 15 $80
Morgan Stanley 0.00% No change 14 $75
Janiczek Wealth Management, LLC 0.00% No change 9 $49
US Bancorp \de 0.00% No change 3 $16
UBS Group AG 0.00% Reduce -99.9% 1 $5
IFP Advisors, Inc 0.00% No change 1 $5

"% of holder's portfolio" is TTOO's weight in each manager's 13F, not the share of T2 Biosystems Inc. the manager owns.